{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:05:01Z","timestamp":1786115101627,"version":"build-2736575974"},"reference-count":16,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001582","name":"Dermatology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jaad.2026.04.022","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T16:20:55Z","timestamp":1776442855000},"page":"467-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hydroxychloroquine use and 5-year cardiometabolic profile and cardiovascular risk in isolated discoid lupus erythematosus: A retrospective cohort study"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-1801-6128","authenticated-orcid":false,"given":"Anjana","family":"Srikumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Yuvchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaad.2026.04.022_bib1","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2025-001637","article-title":"Dyspigmentation and scarring in cutaneous lupus erythematosus","volume":"12","author":"Chambers","year":"2025","journal-title":"Lupus Sci Med"},{"issue":"2","key":"10.1016\/j.jaad.2026.04.022_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jamadermatol.2024.4991","article-title":"Incidence and prevalence of atherosclerotic cardiovascular disease in cutaneous lupus erythematosus","volume":"161","author":"Chen","year":"2025","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2026.04.022_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/0961203316651739","article-title":"Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study","volume":"26","author":"Hesselvig","year":"2017","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.jaad.2026.04.022_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-000908","article-title":"State of current management of the heightened risk for atherosclerotic cardiovascular events in an established cohort of patients with lupus erythematosus","volume":"10","author":"Zhao","year":"2023","journal-title":"Lupus Sci Med"},{"issue":"1","key":"10.1016\/j.jaad.2026.04.022_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaad.2025.02.066","article-title":"Early initiation of hydroxychloroquine in cutaneous lupus erythematosus to prevent progression to systemic lupus erythematosus: a long-term follow-up study","volume":"93","author":"Bar","year":"2025","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2026.04.022_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211073001","article-title":"Hydroxychloroquine in systemic lupus erythematosus: overview of current knowledge","volume":"14","author":"Dima","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"4","key":"10.1016\/j.jaad.2026.04.022_bib7","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jaad.2020.12.013","article-title":"Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: a Danish nationwide cohort study","volume":"84","author":"Haugaard","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2026.04.022_bib8","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/jcm8060796","article-title":"Long-term hydroxychloroquine therapy and risk of coronary artery disease in patients with systemic lupus erythematosus","volume":"8","author":"Yang","year":"2019","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.jaad.2026.04.022_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.32190","article-title":"Hydroxychloroquine and cardiovascular events in patients with systemic lupus erythematosus","volume":"7","author":"Grimaldi","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.jaad.2026.04.022_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10067-020-05257-3","article-title":"Cutaneous lupus erythematosus and cardiovascular disease: current knowledge and insights into pathogenesis","volume":"40","author":"Guo","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.jaad.2026.04.022_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102794","article-title":"Type I interferon as cardiovascular risk factor in systemic and cutaneous lupus erythematosus: a systematic review","volume":"20","author":"Kirchler","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaad.2026.04.022_bib12","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13075-015-0790-3","article-title":"Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus","volume":"17","author":"Virdis","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.jaad.2026.04.022_bib13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/1756-185X.13159","article-title":"Favorable effects of hydroxychloroquine on serum low density lipid in patients with systemic lupus erythematosus: a systematic review and meta-analysis","volume":"21","author":"Babary","year":"2018","journal-title":"Int J Rheum Dis"},{"issue":"5","key":"10.1016\/j.jaad.2026.04.022_bib14","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1365-2133.2012.10825.x","article-title":"The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score","volume":"166","author":"Braunstein","year":"2012","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2026.04.022_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30393","article-title":"Advancements on the impact of hydroxychloroquine in systemic lupus erythematosus","volume":"10","author":"Peng-Cheng","year":"2024","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.jaad.2026.04.022_bib16","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.0022-202X.2005.23889.x","article-title":"The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus","volume":"125","author":"Albrecht","year":"2005","journal-title":"J Invest Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226005591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962226005591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:29:29Z","timestamp":1785976169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962226005591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0190962226005591"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2026.04.022","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxychloroquine use and 5-year cardiometabolic profile and cardiovascular risk in isolated discoid lupus erythematosus: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2026.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}